Crude 1-year mortality rates in patients of the combination fibrate/statin group tended to be lower than in their counterparts of the statin monotherapy group, but this trend did not reach statistical significance.
← all excerpts
Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.
1
—
—